Literature DB >> 11492986

Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.

C Monaco1, F Crea, G Niccoli, F Summaria, D Cianflone, R Bordone, G Bellomo, A Maseri.   

Abstract

BACKGROUND: Antibody antioxidized low density lipoproteins (oxLDL) might play a role both in atherogenesis and in the pathogenesis of acute coronary syndromes. METHODS AND
RESULTS: Antibody titres to oxLDL and levels of C-reactive protein were compared in unstable angina, stable angina or peripheral artery disease. Antibody titres to LDL oxidated by CuSO(4)for 2, 4 and 18 h (Cu-oxLDL-Ab(2-4-18)) or by peroxidase (HRP-oxLDL-Ab) were assessed by ELISA. Cu-oxLDL-Ab(2-4-18)were consistently higher in peripheral artery disease than in unstable angina (P<0.001, P<0.001, P=0.01, respectively) or in stable angina (P<0.001, P=0.01, P=ns) but similar in unstable and stable angina. Accordingly, HRP-oxLDL-Ab were higher in peripheral artery disease than in unstable angina (P<0.001) or stable angina (P=0.04) but similar in unstable and stable angina. The number of arterial stenoses was higher in peripheral artery disease than unstable and stable angina (P<0.01). Cu-oxLDL-Ab and HRP-oxLDL-Ab correlated with the severity of atherosclerosis (P<0.01, R=0.4;P=0.02, R=0.3 respectively). Conversely, C-reactive protein levels were higher in unstable than in stable angina (P<0.001) or in peripheral artery disease (P<0.03) but similar in stable angina and peripheral artery disease and did not correlate with the severity of atherosclerosis.
CONCLUSION: The autoimmune response to oxLDL is likely to play an important role in atherogenesis but not in precipitating acute coronary syndromes. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11492986     DOI: 10.1053/euhj.2000.2554

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Lipoprotein autoantibodies: measurement and significance.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study.

Authors:  Filippo Crea; Claudia Monaco; Gaetano A Lanza; Elena Maggi; Francesca Ginnetti; Domenico Cianflone; Giampaolo Niccoli; Thomas Cook; Giorgio Bellomo; John Kjekshus
Journal:  Clin Cardiol       Date:  2002-10       Impact factor: 2.882

Review 3.  The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.

Authors:  Ricardo F Antunes; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  J Biomed Biotechnol       Date:  2011-12-22

4.  Antioxidized LDL antibodies are associated with different metabolic pathways in patients with atherosclerotic plaque and type 2 diabetes.

Authors:  M Rosa Bernal-Lopez; Lourdes Garrido-Sanchez; Victor Gomez-Carrillo; Jose Luis Gallego-Perales; Vicenta Llorente-Cortes; Fernando Calleja; Ricardo Gomez-Huelgas; Lina Badimon; Francisco J Tinahones
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

5.  Immune response to lipoproteins in atherosclerosis.

Authors:  Sonia Samson; Lakshmi Mundkur; Vijay V Kakkar
Journal:  Cholesterol       Date:  2012-08-23

6.  Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study.

Authors:  Rocío Muñoz-Hernández; Javier Ampuero; Raquel Millán; Antonio Gil-Gómez; Ángela Rojas; Hada C Macher; Rocío Gallego-Durán; Sheila Gato; Rocío Montero-Vallejo; María C Rico; Douglas Maya-Miles; Yolanda Sánchez-Torrijos; Isabel Carmona Soria; Pablo Stiefel; Manuel Romero-Gómez
Journal:  Clin Transl Gastroenterol       Date:  2020-08       Impact factor: 4.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.